Conference abstractPublished 12 Nov 2013
Moving beyond Part 11; Quality assurance considerations for translating cGMP compliance into electronic batch record initiatives
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
With the progression of automated solutions being applied to commercial biopharmaceutical manufacturing, the translation of cGMP to batch recording is necessary for fully realizing the benefits of electronic systems. Most configurable off the shelf applications for process control and manufacturing execution systems (MES) provide full compliance with Part 11, however depending on how those systems are configured, the compliance with cGMPs is variable and requires oversight in the development and deployment by quality to ensure appropriate controls are in place. In order for this be successful, many components are required including the philosophical transition of the quality assurance unit and quality processes as well as adoption of new skill sets of quality professionals. This presentation will discuss considerations for electronic batch record definition, management, execution and reporting to achieve and improve compliance as well as lessons learned including operator/analyst training, human centered design optimization and the elusive search for the pristine batch.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Heather Schwalje”
